Therapeutic plasma exchange in Amatoxin‐associated pediatric acute liver failure—Results from the Amanita‐PEX study

OBJECTIVES: Pediatric acute liver failure (PALF) is a rare but life-threatening condition. Amanita poisoning can lead to PALF with rapid clinical deterioration. Therapeutic plasma exchange (TPE) has been proposed as a potential supportive intervention and is established in adult acute liver failure. Evidence regarding TPE in Amanita toxin-induced PALF (AT-PALF) remains scarce, and clinical practice varies across liver transplant centers. METHODS: The Amanita-PEX study is a retrospective, international, multicenter cohort study including pediatric patients with AT-PALF treated between 2013 and 2024. The combined primary endpoint was 28-day transplant-free survival. RESULTS: A total of 30 patients from 10 centers were included; 17 received at least one session of TPE, and 13 were treated with standard-of-care (SOC) alone. Baseline characteristics were comparable between groups. The overall 28-day transplant-free survival rate was 53.3% (16/30), with a 28-day mortality of 10% (3/30). All patients received N-acetylcysteine, and 93% were treated with silibinin. Native liver survival did not differ significantly between the TPE and SOC groups (47% vs. 62%, p = 0.63). In contrast, transplant-free survival was primarily associated with established markers of liver failure severity and organ dysfunction, including MELD and LIU scores, the degree of hepatic encephalopathy, acute kidney injury, and the need for vasopressors or mechanical ventilation. After adjusting for these prognostic markers, TPE remained unassociated with improved outcomes. CONCLUSIONS: In this real-world cohort of children with AT-PALF, adjunctive TPE showed no clear improvement in transplant-free survival. Outcomes were predominantly determined by the severity of liver injury and multi-organ dysfunction. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT06187220, https://clinicaltrials.gov/study/.

Authors

Institutions

Publication Details

Journal
Journal of Pediatric Gastroenterology and Nutrition
Published
2026-10-29
DOI
https://doi.org/10.1002/jpn3.70626
Primary Topic
Silymarin and Mushroom Poisoning
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Therapeutic plasma exchange in Amatoxin‐associated pediatric acute liver failure—Results from the Amanita‐PEX study

Alexander Fichtner, Heiko Joachim Schenk, Florian von Borell, Ulrich Baumann et al.
3 links
Journal of Pediatric Gastroenterology and Nutrition
Silymarin and Mushroom Poisoning
article

Therapeutic plasma exchange in Amatoxin‐associated pediatric acute liver failure—Results from the Amanita‐PEX study

Alexander Fichtner, Heiko Joachim Schenk, Florian von Borell, Ulrich Baumann, Thomas Jack, Richard Taubert, Angelo Di Giorgio, Eberhard Lurz, Gérladine Dahlqvist, Rainer Büscher, Lorenzo D’Antiga, Daniel Tegtmeyer, Thorben Pape, Marianne Hørby Jørgensen, Tobias Laue, Ekkehard Sturm, Elke Lainka, Klaus Stahl, Eric Levesque, Bente Utoft Andreassen, Dominic Lenz, Nicolas Lanthier, Bahar Nalbant, Isaure Breteau, for the Amanita‐PEX‐study group, Tanja Fritz, Jun Oh
article en

Abstract

OBJECTIVES: Pediatric acute liver failure (PALF) is a rare but life-threatening condition. Amanita poisoning can lead to PALF with rapid clinical deterioration. Therapeutic plasma exchange (TPE) has been proposed as a potential supportive intervention and is established in adult acute liver failure. Evidence regarding TPE in Amanita toxin-induced PALF (AT-PALF) remains scarce, and clinical practice varies across liver transplant centers. METHODS: The Amanita-PEX study is a retrospective, international, multicenter cohort study including pediatric patients with AT-PALF treated between 2013 and 2024. The combined primary endpoint was 28-day transplant-free survival. RESULTS: A total of 30 patients from 10 centers were included; 17 received at least one session of TPE, and 13 were treated with standard-of-care (SOC) alone. Baseline characteristics were comparable between groups. The overall 28-day transplant-free survival rate was 53.3% (16/30), with a 28-day mortality of 10% (3/30). All patients received N-acetylcysteine, and 93% were treated with silibinin. Native liver survival did not differ significantly between the TPE and SOC groups (47% vs. 62%, p = 0.63). In contrast, transplant-free survival was primarily associated with established markers of liver failure severity and organ dysfunction, including MELD and LIU scores, the degree of hepatic encephalopathy, acute kidney injury, and the need for vasopressors or mechanical ventilation. After adjusting for these prognostic markers, TPE remained unassociated with improved outcomes. CONCLUSIONS: In this real-world cohort of children with AT-PALF, adjunctive TPE showed no clear improvement in transplant-free survival. Outcomes were predominantly determined by the severity of liver injury and multi-organ dysfunction. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT06187220, https://clinicaltrials.gov/study/.

Journal of Pediatric Gastroenterology and Nutrition
Cliniques Universitaires Saint-Luc (BE), Universität Hamburg (DE), University of Freiburg (DE), Heidelberg University (DE), University Medical Center Freiburg (DE), University Hospital Heidelberg (DE), Rigshospitalet (DK), LMU Klinikum (DE), Medizinische Hochschule Hannover (DE), Centre Hospitalier Universitaire de Tours (FR), Ospedale Papa Giovanni XXIII (IT), University Medical Center Hamburg-Eppendorf (DE), Kinderkrebs-Zentrum Hamburg (DE), Essen University Hospital (DE), University Children's Hospital Tübingen (DE), German Center for Lung Research (DE), ERN RARE-LIVER (DE), University of Milano-Bicocca (IT), Ludwig-Maximilians-Universität München (DE)
Good health and well-being
Openalex Percentile: Top 12%
Silymarin and Mushroom Poisoning
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon